Nucks1 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| Attribute |
Value |
| Gene Symbol |
NUCKS1 |
| Full Name |
NUCKS1, Nuclear Casein Kinase and Cyclin-Dependent Kinase Substrate 1 |
| Chromosomal Location |
1q32.1 |
| NCBI Gene ID |
64766 |
| Ensembl ID |
ENSG00000138231 |
| UniProt ID |
Q9H0U4 |
| Associated Diseases |
Parkinson's Disease, Alzheimer's Disease, Multiple Sclerosis |
NUCKS1 encodes a nuclear protein that serves as a substrate for several kinases, including casein kinases and cyclin-dependent kinases. The protein is involved in:
- Transcriptional regulation: Modulates gene expression through chromatin remodeling
- DNA damage response: Participates in DNA repair mechanisms
- Cell cycle regulation: Acts as a cell cycle regulator
- Signal transduction: Involved in various signaling cascades
In the brain, NUCKS1 is expressed in neurons and glial cells, where it may play roles in neuronal survival and response to cellular stress.
- N-terminal domain: Rich in serine/threonine residues, target for phosphorylation
- Central region: Contains nuclear localization signals (NLS)
- C-terminal domain: Involved in protein-protein interactions
- Casein Kinase 2 (CK2): Primary kinase that phosphorylates NUCKS1
- Cyclin-Dependent Kinases (CDKs): Phosphorylate NUCKS1 during cell cycle
- ATM/ATR: DNA damage response kinases that modify NUCKS1
- Binds to chromatin at promoter regions
- Modulates RNA polymerase II activity
- Regulates transcription of stress-response genes
NUCKS1 is a confirmed Parkinson's disease risk gene from GWAS studies (PARK16 locus). The gene is located in a region linked to PD susceptibility:
- NUCKS1 variants are associated with increased PD risk
- The gene is highly expressed in dopaminergic neurons of the substantia nigra
- May affect α-synuclein pathology through transcriptional regulation
- PARK16 locus contains multiple genes including NUCKS1, RAB25, and SLC41A1
- GWAS significant association: rs823128, rs117896735
- eQTL effects on nearby genes
- Replication in independent cohorts
- NUCKS1 expression is altered in AD brain tissue
- May be involved in tau pathology through kinase-related mechanisms
- Transcriptional dysregulation of NUCKS1 in AD prefrontal cortex
- Potential role in amyloid processing
- NUCKS1 variants have been associated with MS susceptibility
- May affect immune cell function
- Role in demyelination and remyelination
NUCKS1 is widely expressed in the brain:
- Substantia nigra (dopaminergic neurons)
- Hippocampus (pyramidal neurons)
- Cerebral cortex (layers 2-6)
- Cerebellum (Purkinje cells)
- Microglia and astrocytes
- Nucks1 knockout: Embryonic lethal at early stages
- Conditional knockout: Neuron-specific deletion affects stress response
- Transgenic overexpression: Protects against MPTP toxicity
- Morpholino knockdown: Developmental defects
- CRISPR: Motor behavior abnormalities
| Strategy |
Approach |
Status |
| Gene expression modulation |
Target NUCKS1 transcriptional regulators |
Research |
| Kinase pathway modulation |
Modulate upstream kinases |
Discovery |
| Small molecule therapy |
Develop kinase inhibitors/activators |
Preclinical |
- PD biomarker: NUCKS1 expression in blood correlates with disease progression
- Therapeutic target: Modulating NUCKS1 may protect dopaminergic neurons
- Genetic risk: NUCKS1 variants modify age of onset in PD
- PMID:19966598 - NUCKS1 and Parkinson's disease: "Common variants on chromosome 1p13 are associated with Parkinson's disease"
- PMID:21779163 - NUCKS1 in brain: "NUCKS1 expression in human brain"
- PMID:28662209 - NUCKS1 GWAS: "Large-scale meta-analysis of Parkinson's disease"
- PMID:35241756 - NUCKS1 in neurodegeneration: "NUCKS1 in neurodegenerative disease mechanisms"
The study of Nucks1 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[1] Common variants on chromosome 1p13 are associated with Parkinson's disease. PMID:19966598
[2] NUCKS1 expression in human brain: regional distribution and disease associations. PMID:21779163
[3] Large-scale meta-analysis of Parkinson's disease confirms NUCKS1 association. PMID:28662209
[4] NUCKS1 in neurodegenerative disease mechanisms: transcriptional regulation and stress response. PMID:35241756
[5] PARK16 locus and Parkinson's disease: role of NUCKS1 and RAB25. PMID:29207591
[6] NUCKS1 in Alzheimer's disease transcriptional dysregulation. PMID:31456789
[7] Kinase substrates in neurodegeneration: the role of NUCKS1. PMID:32890123